[Problems of the immunotherapy of malignant neoplasma].
D000818:Animals; D000917:Antibody Formation; D000951:Antigens, Neoplasm / Q000008:administration & dosage; D000961:Antilymphocyte Serum / Q000627:therapeutic use; D001500:BCG Vaccine; D004305:Dose-Response Relationship, Drug; D006801:Humans; D007110:Immunity, Active; D007112:Immunity, Maternally-Acquired; D007114:Immunization; D007165:Immunosuppression Therapy; D007167:Immunotherapy / Q000379:methods; D007938:Leukemia / Q000628:therapy; D017708:Leukocyte Transfusion; D017710:Lymphocyte Transfusion; D008545:Melanoma / Q000628:therapy; D009362:Neoplasm Metastasis; D009368:Neoplasm Transplantation; D009369:Neoplasms / Q000276:immunology / Q000628:therapy*; D012516:Osteosarcoma / Q000628:therapy; D012075:Remission, Spontaneous; D014181:Transplantation Immunology; D014183:Transplantation, Heterologous
D000951:Antigens, Neoplasm; D000961:Antilymphocyte Serum; D001500:BCG Vaccine
Problemy immunoterapii zlokachestvennykh opukhole-56i